June 20, 2025, 16:00 EDT
Invested in the Future of Cardiovascular Medicine
Our purpose is driven by our vision to stop cardiovascular disease from being a leading cause of death worldwide. Amarin is a global pharmaceutical company developing new treatments to fight against cardiovascular disease. Amarin is relentless in its pursuit of scientific breakthroughs that can lead to revolutionary treatments to create a healthier world. Find out more about who we are, what we stand for and how we are making a difference in the lives of patients.
Upcoming Events and Latest Presentations
Click a link below for access to our events.
Latest News From Amarin
From research results, financial toolkits and webcasts to important investor information and financial governance. Find out the latest financial news about Amarin in these publications.
Investor Contact Form
For corporate governance, analyst coverage, stock information, secretarial matters and other investor-related queries, please use the Contact form
Financial Information
Balancing Passion with Resolution
Learn more about Amarin’s revenue, expenses, profit and loss, as well as a comprehensive overview of the company’s financial health.
About Amarin for Investors
Amarin is a leading cardiovascular health pharmaceutical company. As leaders, we apply science, research, passion and global knowledge to ensure we further our vision of stopping cardiovascular disease from being a leading cause of death. In order to achieve this vision, we take a strategic approach to management and financial responsibility.
Corporate Governance
Gain new insights into Amarin’s performance and corporate commitments.
Analyst Coverage
Find out which firms and analysts are covering Amarin.
Stock Information
View real-time stock prices and stock quotes.
About Amarin
A new paradigm in cardiovascular health management
Amarin Corporation is focused on a BOLD vision to stop cardiovascular disease from being a leading cause of death. Find out more about our vision and how we lead the way to better care for those with cardiovascular disease.
Science and Health
Passionate about cardiometabolic science and health
Learn more about the science underpinning our product and research & development efforts to advance innovation in cardiovascular disease.
News and Media
Press releases, news, updates and statements
From reports and reviews to partnerships and innovations, find out more about Amarin's latest news and stories as they stand in the press.
ALL-NP-00016 1/23
You are about to review presentations, reports, filings and/or other materials regarding Amarin Corporation plc (NASDAQ: AMRN) that contain time-sensitive information.
The information contained therein is only current as of the date thereof and may not be a complete listing of all documents filed with the Securities Exchange Commission, made public or provided to Amarin shareholders.
Amarin expressly disclaims any obligation to review, update or correct these materials after the date thereof. Amarin may update, amend, supplement or otherwise alter the information contained in any such materials by subsequent presentations, reports, filings, or other means without notice.
Certain statements made on this web site or in materials accessed in or through the investor relations section of our web site are "forward-looking statements," which are subject to risks and uncertainties, and Amarin's actual results may differ (possibly materially) from those indicated in such statements. A further list and description of these risks, uncertainties and other risks associated with an investment in Amarin can be found in Amarin's filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and its most recent Quarterly Report on Form 10-Q.
This website is not an offer or a solicitation to buy or sell securities. Please be aware that decisions regarding investments are the responsibility of users. Although this website includes information regarding pharmaceuticals (including products under development), the information is not intended as any advertisement and/or medical advice.
This information is intended for communication with investors and should not be construed as marketing the use of any Amarin products or product candidates.
Information on this website may be revised without any prior notice.